Bingbing Dai
About Bingbing Dai
Bingbing Dai is the Director of Translational Science at BeiGene and a Senior Principal Scientific Researcher at Genentech, with extensive experience in immuno-engineering and clinical biomarkers.
Company
Bingbing Dai currently holds a position at BeiGene, a global biopharmaceutical company. As the Director of Translational Science, Dai focuses on bridging the gap between laboratory research and clinical applications. BeiGene is known for its innovative approaches in the treatment of cancer, making Dai's role critical to advancing clinical strategies and biomarker discoveries.
Title
Bingbing Dai holds dual roles in the biotechnology industry. At BeiGene, Dai serves as the Director of Translational Science, while concurrently working at Genentech as a Senior Principal Scientific Researcher. These titles reflect a significant level of expertise and involvement in transformative scientific research and translational applications.
Education and Expertise
Bingbing Dai completed a Ph.D. in Chemical Engineering with a specialization in immuno-engineering and immunology from the University of Southern California. Prior to this, Dai earned a B.S. in Polymer Science & Engineering from Fudan University. These academic credentials underpin a robust foundation in both engineering and biomedical sciences, facilitating impactful contributions in translational science and clinical biomarker research.
Professional Background
Bingbing Dai's professional journey includes significant roles and contributions in academia and industry. From 2015 to 2021, Dai worked at Genentech, starting as a Principal Scientific Researcher and later becoming a Senior Principal Scientific Researcher. Before that, Dai was a post-doctoral scholar at UC Davis in Biomedical Engineering from 2012 to 2014, contributing to various projects focused on biomedical engineering. The early research career began as a Ph.D. candidate and researcher at the University of Southern California from 2006 to 2012.
Achievements
Bingbing Dai has been instrumental in advancing clinical biomarkers and translational science. At BeiGene, Dai plays a crucial role in bridging the gap between research and clinical application. During the tenure at UC Davis, Dai contributed to significant biomedical engineering projects, leveraging a strong background in immuno-engineering and immunology. This extensive experience has positioned Dai as a key player in ongoing advancements within the field.